Azithromycin Featured News
14 items
-
9
NovZhejiang Guobang Pharmaceutical and Jiangsu Kaiyuan Pharmaceutical signed a strategic cooperation agreement
On November 6, 2021, Guobang Pharmaceutical Group Co., Ltd. and Jiangsu Kaiyuan Pharmaceutical Co., Ltd. signed a strategic cooperation agreement in Hangzhou, Zhejiang. -
1
SepDechuang Environmental Protection and Guobang Pharmaceutical Co., Ltd. strategically cooperate to jointly create a demonstration project for hazardous waste packaging and disposal
Recently, Techuang Environmental Protection and Zhejiang Guobang Pharmaceutical Co., Ltd. reached a strategic cooperation. -
20
JulZhejiang Guobang Pharmaceutical's 2020 operating income of 4.2 billion yuan, net profit of 810 million yuan
-
20
JulZhejiang Guobang Pharmaceutical's production capacity of erythromycin and other APIs and intermediate products in 2020
Zhejiang Guobang Pharmaceutical's production capacity of erythromycin and other APIs and intermediate products in 2020 -
20
JulProduction and sales statistics of erythromycin and other APIs of Zhejiang Guobang Pharmaceutical from 2018 to 2020
Production and sales statistics of erythromycin and other APIs of Zhejiang Guobang Pharmaceutical from 2018 to 2020 -
24
JunGuangdong Taisende Pharmaceutical Construction of Macrolide Erythromycin API Production Project
The public announcement of the environmental impact assessment of the synthetic production line construction project -
16
JunZhejiang Guobang Pharmaceutical's 'Key Technology Innovation and Application of Macrolide Antibiotics Quality Control' project won the third prize of the Provincial Science and Technology Progress Awa
On June 15, 2021, the Zhejiang Science and Technology Awards Conference was held in the Great Hall of the People in Zhejiang Province. -
26
MarProduction volume and sales volume of azithromycin API in Shanghai Hyundai Pharmaceutical in 2020
-
26
MarNingxia Hengkang Technology Co., Ltd. invests in the technical transformation project with an annual output of 200 tons of erythromycin
Project name: erythromycin technological transformation investment project with an annual output of 200 tons -
4
MarYili Chuanning Biotechnology Co., Ltd. was approved to establish a post-doctoral research station
Yili Chuanning Biotechnology Co., Ltd. has recently been approved to establish an autonomous region-level post-doctoral research station. -
25
FebEast Sunshine Yidu Base will achieve sales revenue of 19.315 billion yuan in 2020
On February 5, the 2020 Annual Summary and Advanced Commendation Conference of Dongyang Sunshine Yidu Base was held in Yidu City, Hubei Province. -
9
FebHubei Province Fine Chemical Risk Laboratory was completed in Yichang Dongyangguang Pharmaceutical Co., Ltd.
On January 27, the first fine chemical risk laboratory in Hubei Province was completed in the technical center of Yichang Dongyang Sunshine Pharmaceutical Co., Ltd. -
20
JanChanges in the monthly measurement prices of macrolide APIs exported to India in 2020
-
15
JanZhejiang Guobang Pharmaceutical's foreign trade upgrade road, the export of raw materials in 2020 will exceed 1.3 billion yuan
Guobang Pharmaceutical
Breaking News
-
[Base Oil]: Asian Base Oil Price Table (20260603)
Jun 3 -
[Urea]: International Mainstream Regional Urea Export FOB Price (20260605)
Jun 5 -
[Urea]: International Urea Price Closing Week (20260605)
Jun 5 -
[EVA]: Quick Update on Hanwha EVA’s New USD Quotations from South Korea (2026-06-10)
Jun 10 -
[Glacial Acetic Acid]: Price Trends in the South China Market (2026-06-10)
Jun 10 -
[Maleic Anhydride Daily Review]: Maleic Anhydride Market Center Still Shifts Up (20260610)
Jun 10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)